Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients

35Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We examined the expression of cytokeratin 20 (CK20) mRNA in the peripheral blood of oral squamous cell carcinoma (SCC) patients by reverse transcriptase polymerase chain reaction (RT-PCR). Eleven out of 12 oral SCC patients showed positive RT-PCR results. However, there is no clear relationship between the haematogenous CK20 mRNA and the metastasis. After initial treatment, all of the tumour-free survivors tested showed negative RT-PCR results. CK20 mRNA in peripheral blood can be used as a marker for tumour recurrence but not for metastasis in oral SCC patients.

Author supplied keywords

Cite

CITATION STYLE

APA

Kawamata, H., Uchida, D., Nakashiro, K., Hino, S., Omotehara, F., Yoshida, H., & Sato, M. (1999). Haematogenous cytokeratin 20 mRNA as a predictive marker for recurrence in oral cancer patients. British Journal of Cancer, 80(3–4), 448–452. https://doi.org/10.1038/sj.bjc.6690377

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free